Court documents reveal Monsanto’s efforts to fight glyphosate’s ‘severe stigma’

A review by CBC/Radio-Canada of internal Monsanto documents disclosed in the court case of Dewayne Johnson, who sued Monsanto and won $78 million last October, showed the many efforts the company took to fight the IARC assessment.
The documents also reveal communications between Monsanto and a Canadian firm hired to recruit scientists to publish studies that ultimately defended glyphosate — some of which were secretly reviewed by Monsanto prior to publication. All those papers, as previously reported by CBC/Radio-Canada, were also used as part of Health Canada’s re-approval process of glyphosate in 2017.
All five papers claimed they were written by independent experts and said that no Monsanto employees or lawyers reviewed the manuscripts prior to publication.
“I would put a large flag of concern around the quality and integrity of those papers,” McLaughlin adds.
This was not the first time that Monsanto turned to Intertek to defend glyphosate. Cantox, purchased by Intertek in 2010, worked on a major glyphosate safety analysis in 1999, which concluded “Roundup herbicide does not pose a health risk to humans.” The study would go on to be cited over 500 times in the academic literature.
Once again, Monsanto’s Heydens discussed ghostwriting a paper and having outside scientists sign it.
Ad below this line: